Skip to main content
Top
Published in: Endocrine 1/2017

01-10-2017 | Letter to the Editor

Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients

Authors: Hershel Raff, David J Kramer, Cecilia J. Hillard

Published in: Endocrine | Issue 1/2017

Login to get access

Excerpt

The endocannabinoid signaling system consists of two G-protein-coupled receptors (CBRs), named CB1 and CB2, and two well-characterized ligands, the endocannabinoids (eCBs) 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (AEA) [1]. Although the roles of these molecules in the circulation are not well understood, their concentrations change under the conditions of physiological and psychological stress [1]. In particular, 2-AG and AEA concentrations have been reported to be increased in patients with endotoxic shock, infection, and following cardiac surgery [1]. To further our understanding of the roles of endocannabinoids in human disease states associated with severe physiological stress, we compared circulating concentrations of 2-AG and AEA in blood obtained from septic patients within 24 h of admission to the ICU to the same measures in healthy controls. …
Literature
3.
go back to reference P.A. Spagnolo, V.A. Ramchandani, M.L. Schwandt, L.E. Kwako, D.T. George, L.M. Mayo, C.J. Hillard, M. Heilig, FAAH Gene variation moderates stress response and symptom severity in patients with posttraumatic stress disorder and comorbid alcohol dependence. Alcohol Clin Exp Res 40(11), 2426–2434 (2016). https://doi.org/10.1111/acer.13210 CrossRefPubMed P.A. Spagnolo, V.A. Ramchandani, M.L. Schwandt, L.E. Kwako, D.T. George, L.M. Mayo, C.J. Hillard, M. Heilig, FAAH Gene variation moderates stress response and symptom severity in patients with posttraumatic stress disorder and comorbid alcohol dependence. Alcohol Clin Exp Res 40(11), 2426–2434 (2016). https://​doi.​org/​10.​1111/​acer.​13210 CrossRefPubMed
Metadata
Title
Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients
Authors
Hershel Raff
David J Kramer
Cecilia J. Hillard
Publication date
01-10-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1399-x

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.